Literature DB >> 19193908

Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the third international workshop.

John P Bilezikian1, Aliya A Khan, John T Potts.   

Abstract

OBJECTIVE: Asymptomatic primary hyperparathyroidism (PHPT) is a common clinical problem. The purpose of this report is to guide the use of diagnostics and management for this condition in clinical practice. PARTICIPANTS: Interested professional societies selected representatives for the consensus committee and provided funding for a one-day meeting. A subgroup of this committee set the program and developed key questions for review. Consensus was established at a closed meeting that followed and at subsequent discussions. EVIDENCE: Each question was addressed by a relevant literature search (on PubMed), and the data were presented for discussion at the group meeting. CONSENSUS PROCESS: Consensus was achieved by a group meeting. Statements were prepared and reviewed by all authors who represented the Planning Committee and the participating professional societies.

Entities:  

Mesh:

Year:  2009        PMID: 19193908      PMCID: PMC3214274          DOI: 10.1210/jc.2008-1763

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  4 in total

Review 1.  Surgery for asymptomatic primary hyperparathyroidism: proceedings of the third international workshop.

Authors:  Robert Udelsman; Janice L Pasieka; Cord Sturgeon; J E M Young; Orlo H Clark
Journal:  J Clin Endocrinol Metab       Date:  2009-02       Impact factor: 5.958

Review 2.  Medical management of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop.

Authors:  Aliya Khan; Andrew Grey; Dolores Shoback
Journal:  J Clin Endocrinol Metab       Date:  2009-02       Impact factor: 5.958

Review 3.  Diagnosis of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop.

Authors:  R Eastell; A Arnold; M L Brandi; E M Brown; P D'Amour; D A Hanley; D Sudhaker Rao; M R Rubin; D Goltzman; S J Silverberg; S J Marx; M Peacock; L Mosekilde; R Bouillon; E M Lewiecki
Journal:  J Clin Endocrinol Metab       Date:  2009-02       Impact factor: 5.958

Review 4.  Presentation of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop.

Authors:  Shonni J Silverberg; E Michael Lewiecki; Leif Mosekilde; Munro Peacock; Mishaela R Rubin
Journal:  J Clin Endocrinol Metab       Date:  2009-02       Impact factor: 5.958

  4 in total
  185 in total

1.  Effect of parathyroidectomy on subclinical cardiovascular disease in mild primary hyperparathyroidism.

Authors:  M D Walker; T Rundek; S Homma; M DiTullio; S Iwata; J A Lee; J Choi; R Liu; C Zhang; D J McMahon; R L Sacco; S J Silverberg
Journal:  Eur J Endocrinol       Date:  2012-06-01       Impact factor: 6.664

2.  [Calcimimetics: no competition for surgery in primary hyperparathyroidism].

Authors:  K Lorenz
Journal:  Chirurg       Date:  2012-04       Impact factor: 0.955

Review 3.  [Primary hyperparathyroidism - current diagnosis and therapy].

Authors:  Kristina Pluemacher; Heide Siggelkow
Journal:  Med Klin (Munich)       Date:  2010-08

4.  Reduced coronary flow reserve in patients with primary hyperparathyroidism: a study by G-SPECT myocardial perfusion imaging.

Authors:  Cecilia Marini; Massimo Giusti; Riccardo Armonino; Giorgio Ghigliotti; GianPaolo Bezante; Lara Vera; Silvia Morbelli; Elena Pomposelli; Michela Massollo; Patrizia Gandolfo; Francesco Minuto; Gianmario Sambuceti
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-09-04       Impact factor: 9.236

5.  Persistent symptomatic improvement in the majority of patients undergoing parathyroidectomy for primary hyperparathyroidism.

Authors:  Preethi Gopinath; Gregory P Sadler; Radu Mihai
Journal:  Langenbecks Arch Surg       Date:  2010-07-25       Impact factor: 3.445

Review 6.  [Intraoperative parathyroid hormone determination for primary hyperparathyroidism].

Authors:  K Lorenz; H Dralle
Journal:  Chirurg       Date:  2010-07       Impact factor: 0.955

7.  Cardiovascular risk and metabolic syndrome in primary hyperparathyroidism and their correlation to different clinical forms.

Authors:  M Procopio; M Barale; S Bertaina; S Sigrist; R Mazzetti; M Loiacono; G Mengozzi; E Ghigo; M Maccario
Journal:  Endocrine       Date:  2013-11-28       Impact factor: 3.633

8.  Classic Primary Hyperparathyroidism Versus Normocalcemic and Normohormonal Variants: Do They Really Differ?

Authors:  Andreas Kiriakopoulos; Athanasios Petralias; Dimitrios Linos
Journal:  World J Surg       Date:  2018-04       Impact factor: 3.352

9.  Predictors of renal function in primary hyperparathyroidism.

Authors:  Marcella D Walker; Thomas Nickolas; Anna Kepley; James A Lee; Chiyuan Zhang; Donald J McMahon; Shonni J Silverberg
Journal:  J Clin Endocrinol Metab       Date:  2014-02-14       Impact factor: 5.958

10.  Skeletal changes after restoration of the euparathyroid state in patients with hypoparathyroidism and primary hyperparathyroidism.

Authors:  Cristiana Cipriani; Alice Abraham; Barbara C Silva; Natalie E Cusano; Mishaela R Rubin; Donald J McMahon; Chengchen Zhang; Didier Hans; Shonni J Silverberg; John P Bilezikian
Journal:  Endocrine       Date:  2016-10-18       Impact factor: 3.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.